Fig. 3From: Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinomaKaplan–Meier survival analyses of patients. Patients were divided into high-risk and low-risk group based on the median risk score to predict overall survival (OS) and progression-free survival (PFS) in each subgroup. a OS in the training group. b OS in the testing group. c OS in all groups. d PFS in all groupsBack to article page